Clinical Trial Update: Preoperative CRT With Temozolomide Plus Capecitabine in Rectal Cancer [Phase 1]

View source ↗

Summary

Phase 1 trial update evaluating preoperative chemoradiation with temozolomide plus capecitabine in rectal cancer has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Cancer

Drugs mentioned

• Capecitabine (capecitabine)
• Temozolomide (Temozolomide)

Snippet

Sponsor: Asan Medical Center | Conditions: Rectal Cancer | Phase 1 | Status: COMPLETED | Results posted: 2016-06-23